Transforming growth factor P signaling controls activities of human intestinal CD8(+)T . suppressor cells.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 111
- By:
- Publication type:
- Article
Works matching IS 14667401 AND DT 2013 AND VI 13 AND IP 3
Results: 33
1
2
Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 123
- By:
- Publication type:
- Article
3
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 122
- By:
- Publication type:
- Article
4
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 121
- By:
- Publication type:
- Article
5
EVENTS 2013.
- Published in:
- 2013
- Publication type:
- Calendar
6
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 124
- By:
- Publication type:
- Article
7
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
8
IL-22BP is regulated by the inflammasome and modulates tumoriqenesis in the intestine.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 108
- By:
- Publication type:
- Article
9
Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 122
- By:
- Publication type:
- Article
10
Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 121
- By:
- Publication type:
- Article
11
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 120
- By:
- Publication type:
- Article
12
Long-term outcome of patients with Crohn's disease that responds to azathioprine.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 119
- By:
- Publication type:
- Article
13
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 118
- By:
- Publication type:
- Article
14
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 118
- By:
- Publication type:
- Article
15
When independent healthcare behaviors develop in adolescents with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 117
- By:
- Publication type:
- Article
16
Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 117
- By:
- Publication type:
- Article
17
Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 116
- By:
- Publication type:
- Article
18
Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 116
- By:
- Publication type:
- Article
19
Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 115
- By:
- Publication type:
- Article
20
Clinical course of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomoses.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 114
- By:
- Publication type:
- Article
21
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 114
- By:
- Publication type:
- Article
22
Does smoking influence Crohn's disease in the biologic era? The TABACROHN study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 113
- By:
- Publication type:
- Article
23
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 113
- By:
- Publication type:
- Article
24
A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 112
- By:
- Publication type:
- Article
25
Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair/Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 111
- By:
- Publication type:
- Article
26
An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 110
- By:
- Publication type:
- Article
27
The σE pathway is involved in biofilm formation by Crohn's disease-associated adherent-invasive Escherichia coil.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 110
- By:
- Publication type:
- Article
28
Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 109
- By:
- Publication type:
- Article
29
IL-i OR polymorphisms are associated with very-early- onset ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 109
- By:
- Publication type:
- Article
30
Intestinal inflammation targets cancer-inducing activity of the microbiota.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 108
- By:
- Publication type:
- Article
31
eHealth for IBD: First Steps in the Transformation to Value-Based Healthcare Delivery.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 100
- By:
- Publication type:
- Article
32
Helminthic Therapy in IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 93
- By:
- Publication type:
- Article
33
Visceral Hypersensitivity and IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 3, p. 85
- By:
- Publication type:
- Article